Skip to main content
. 2016 Feb 1;11:515–534. doi: 10.1007/s11523-015-0411-8

Fig. 2.

Fig. 2

Drugs characteristics: tumour type (a), number of indication (b), administration mode (c), pharmacological class (d). Note: Data reported for 31 drugs indicated in solid tumours having centralized EU authorisation, 2009-2014. *1 drug targeting 3 types of cancer and 1 drug targeting 2 types of cancer